Baker Biotech Capital (GP), LLC insider trades: Tranzyme (TZYM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Baker Biotech Capital (GP), LLC reports to the SEC
and 11 more companies
Open-market buys and sales
130 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 14, 2012 | TZYM | ↑ Buy | 121,981 | $2.56 | $312K | Through Partnership | Mar 14, 2012 (0d) |
| Mar 8, 2012 | GHDX | ↑ Buy | 4,508 | $30.11 | $136K | Through Partnership | Mar 9, 2012 (1d) |
| Mar 5, 2012 | GHDX | ↑ Buy | 31,332 | $29.81 | $934K | Through Partnership | Mar 5, 2012 (0d) |
| Feb 29, 2012 | GHDX | ↑ Buy | 29,756 | $29.06 | $865K | Through Partnership | Feb 29, 2012 (0d) |
| Feb 23, 2012 | GHDX | ↑ Buy | 13,332 | $28.06 | $374K | Through Partnership | Feb 23, 2012 (0d) |
| Feb 16, 2012 | GHDX | ↑ Buy | 33,185 | $29.34 | $974K | Through Partnership | Feb 16, 2012 (0d) |
| Feb 10, 2012 | PCYC | ↑ Buy | 150,000 | $20.85 | $3.1M | Through Partnership | Feb 14, 2012 (4d) |
| Feb 10, 2012 | GHDX | ↑ Buy | 66,583 | $26.36 | $1.8M | Through Partnership | Feb 10, 2012 (0d) |
| Jan 26, 2012 | PCYC | ↑ Buy | 85,993 | $18.09 | $1.6M | Through Partnership | Jan 26, 2012 (0d) |
| Jan 23, 2012 | PCYC | ↑ Buy | 77,425 | $16.55 | $1.3M | Through Partnership | Jan 23, 2012 (0d) |
| Dec 14, 2011 | VPHM | ↑ Buy | 50,566 | $27.29 | $1.4M | Through Partnership | Dec 16, 2011 (2d) |
| Dec 5, 2011 | GHDX | ↑ Buy | 45,977 | $27.66 | $1.3M | Through Partnership | Dec 5, 2011 (0d) |
| Dec 2, 2011 | PCYC | ↑ Buy | 14,561 | $15.42 | $224K | Through Partnership | Dec 6, 2011 (4d) |
| Nov 30, 2011 | PCYC | ↑ Buy | 64,799 | $13.97 | $905K | Through Partnership | Nov 30, 2011 (0d) |
| Nov 23, 2011 | GHDX | ↑ Buy | 5,531 | $25.91 | $143K | Through Partnership | Nov 23, 2011 (0d) |
| Nov 23, 2011 | PCYC | ↑ Buy | 7,351 | $12.63 | $93K | Through Partnership | Nov 23, 2011 (0d) |
| Nov 16, 2011 | GHDX | ↑ Buy | 458 | $27.35 | $13K | Through Partnership | Nov 17, 2011 (1d) |
| Nov 9, 2011 | GHDX | ↑ Buy | 542 | $26.79 | $15K | Through Partnership | Nov 14, 2011 (5d) |
| Nov 3, 2011 | GHDX | ↑ Buy | 120 | $24.48 | $3K | Through Partnership | Nov 7, 2011 (4d) |
| Oct 5, 2011 | VPHM | ↑ Buy | 18,789 | $18.09 | $340K | Through Partnership | Oct 6, 2011 (1d) |
| Oct 3, 2011 | PCYC | ↑ Buy | 111,163 | $11.64 | $1.3M | Through Partnership | Oct 4, 2011 (1d) |
| Sep 30, 2011 | VPHM | ↑ Buy | 53,205 | $18.04 | $960K | Through Partnership | Oct 3, 2011 (3d) |
| Sep 26, 2011 | VPHM | ↑ Buy | 72,849 | $17.84 | $1.3M | Through Partnership | Sep 26, 2011 (0d) |
| Aug 23, 2011 | VPHM | ↑ Buy | 5,468 | $16.97 | $93K | Through Partnership | Aug 25, 2011 (2d) |
| Aug 22, 2011 | PCYC | ↑ Buy | 39,710 | $9.96 | $396K | Through Partnership | Aug 24, 2011 (2d) |
| Aug 2, 2011 | AUXL | ↓ Sell | 108,570 | $17.99 | $2.0M | Through Partnership | Aug 3, 2011 (1d) |
| Oct 29, 2010 | ADLR | ↓ Sell | 2,063 | $1.23 | $3K | Through Partnership | Oct 29, 2010 (0d) |
| Sep 23, 2010 | INCY | ↓ Sell | 397,050 | $14.88 | $5.9M | Through Partnership | Sep 23, 2010 (0d) |
| Aug 10, 2010 | INCY | ↓ Sell | 156,929 | $14.06 | $2.2M | Through Partnership | Aug 11, 2010 (1d) |
| May 10, 2010 | VPHM | ↓ Sell | 847,786 | $12.65 | $10.7M | Through Partnership | May 10, 2010 (0d) |
| Apr 30, 2010 | VPHM | ↑ Buy | 1,242,004 | $12.94 | $16.1M | Through Partnership | May 4, 2010 (4d) |
| Aug 17, 2009 | GHDX | ↑ Buy | 11,657 | $19.98 | $233K | Through Partnership | Aug 17, 2009 (0d) |
| Aug 12, 2009 | GHDX | ↑ Buy | 15,877 | $19.49 | $309K | Through Partnership | Aug 12, 2009 (0d) |
| Aug 11, 2009 | SGEN | ↑ Buy | 273,404 | $10.75 | $2.9M | Through Partnership | May 4, 2010 (266d) |
| Jun 1, 2009 | BCRX | ↓ Sell | 236,478 | $4.22 | $998K | Through Partnership | Jun 1, 2009 (0d) |
| May 20, 2009 | SGEN | ↑ Buy | 378,053 | $9.72 | $3.7M | Through Partnership | May 20, 2009 (0d) |
| Mar 5, 2009 | INCY | ↑ Buy | 3,447 | $2.15 | $7K | Through Partnership | Mar 5, 2009 (0d) |
| Mar 2, 2009 | INCY | ↑ Buy | 7,701 | $2.15 | $17K | Through Partnership | Mar 2, 2009 (0d) |
| Feb 6, 2009 | ALTH | ↓ Sell | 781,599 | $8.25 | $6.5M | Through Partnership | Feb 6, 2009 (0d) |
| Dec 19, 2008 | RDEA | ↑ Buy | 184,780 | $11.14 | $2.1M | Through Partnership | Dec 19, 2008 (0d) |
| Dec 19, 2008 | RDEA | ↑ Buy | 184,780 | $11.14 | $2.1M | Through Partnership | Dec 19, 2008 (0d) |
| Dec 19, 2008 | INCY | ↑ Buy | 227,270 | $3.50 | $797K | Through Partnership | Dec 19, 2008 (0d) |
| Nov 24, 2008 | BCRX | ↑ Buy | 108,203 | $0.99 | $107K | Through Partnership | Nov 24, 2008 (0d) |
| Jul 31, 2008 | INCY | ↑ Buy | 201,648 | $9.00 | $1.8M | Through Partnership | Aug 5, 2008 (5d) |
| Jul 29, 2008 | IDP | ↓ Sell | 12,791 | $14.92 | $191K | Through Partnership | Jul 30, 2008 (1d) |
| Jul 25, 2008 | IDP | ↓ Sell | 34,437 | $14.97 | $516K | Through Partnership | Jul 25, 2008 (0d) |
| Jul 17, 2008 | IDP | ↓ Sell | 18,449 | $14.80 | $273K | Through Partnership | Jul 21, 2008 (4d) |
| Jul 14, 2008 | IDP | ↓ Sell | 8,579 | $15.24 | $131K | Through Partnership | Jul 16, 2008 (2d) |
| Jul 1, 2008 | IDP | ↓ Sell | 183,400 | $15.36 | $2.8M | Through Partnership | Jul 1, 2008 (0d) |
| Jun 9, 2008 | GHDX | ↑ Buy | 76,015 | $19.91 | $1.5M | Through Partnership | Jun 9, 2008 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Baker Biotech Capital (GP), LLC's insider trades
Baker Biotech Capital (GP), LLC is a 10% owner of Tranzyme (TZYM). Since Apr 29, 2005, it has reported 102 open-market purchases worth $112.2M and 28 sales worth $53.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (13 filings), conversions (5 filings), option exercises (3 filings), grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TZYM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.